Executive Summary
Syntopix Group plc is engaged in the discovery and development of drugs for the topical treatment of common dermatological diseases, currently focussing on acne and superficial Staphylococcus aureus infections.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
